FDA Adverse Event Injury Summary report: N

ION PACLITAXEL-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM

MDR report key: 2101059 · Received May 24, 2011

Report

Report Number
2134265-2011-01855
Event Type
Injury
Date Received
May 24, 2011
Date of Event
March 25, 2011
Report Date
April 25, 2011
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P100023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. PATIENT IDENTIFIER - (B)(6). DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(4). IT WAS REPORTED THAT POST A CORONARY STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED MYOCARDIAL INFARCTION. THE 90% STENOSED TARGET LESION LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING(LAD) WAS 3.5MM DIAMETER AND 16MM LONG. THE LESION WAS TREATED WITH PREDILATION AND PLACEMENT OF A 3.5X20MM STUDY STENT. RESIDUAL STENOSIS WAS 0%. THE PATIENT WAS DISCHARGED 1 DAY LATER ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2011, THE PATIENT WAS ADMITTED WITH MYOCARDIAL INFARCTION (MI). ANGIOGRAPHY WAS PERFORMED BUT, NO REVASCULARIZATION DONE. THE LOCATION OF THE MI WAS REPORTED AS "NOT IDENTIFIABLE." THE PATIENT WAS DISCHARGED 1 DAY LATER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ION PACLITAXEL-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK692 11068823

Patients

Seq Age Sex Outcome Treatment
1 55 YR Other